Skip to main content
. 2015 Sep 14;10(9):e0137800. doi: 10.1371/journal.pone.0137800

Fig 2. Cell viability assay.

Fig 2

(A) Cytotoxic activity of compounds 1, 2, and 5 against cancer cells. The indicated cell lines were treated for 48 h with ligands (10 μmol/L) and cell viability was measured with the MTT assay. Data represents the percentage of viable cells relative to untreated cells (control). (B) Cytotoxicity of doxorubicin and compounds 1, 2 and 5 against CS-like cells. CS-like HMLER-shEcad cells and non-CS-like HMLER isogenic parental cells were treated for 48 h with graded concentrations of doxorubicin, 1, 2 and 5. Cell viability was measured with the MTT assay. For each treatment, the percentage of viable cells relative to untreated cells is indicated. Data represents the mean±SD of 3 independent experiments performed in triplicate.